Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in Ependymoma1

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Immunology

• Publication date

  2009-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.0902811PMID 19917695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromatin Immunoprecipitation

  2020cited by this paper
• The anticancer immune response: indispensable for therapeutic success?

  2008cited by this paper
• Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.

  2008cited by this paper
• Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells

  2008cited by this paper
• Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.

  2008cited by this paper
• Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker

  2008cited by this paper
• IRF7 activation by Epstein–Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

  2008cited by this paper
• The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors

  2008cited by this paper
• Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma.

  2008cited by this paper
• Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival

  2007cited by this paper
• Mechanisms of killing by anti-CD20 monoclonal antibodies.

  2007cited by this paper
• X-ray structures of the microglia/macrophage-specific protein Iba1 from human and mouse demonstrate novel molecular conformation change induced by calcium binding.

  2006influential reference
• Innate immune functions of microglia isolated from human glioma patients

  2006cited by this paper
• A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

  2006cited by this paper
• Predicting which children are at risk for ependymoma relapse

  2006cited by this paper
• Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.

  2006cited by this paper
• Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.

  2005cited by this paper
• Ependymal tumors in childhood

  2005cited by this paper
• Tumor HLA‐DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma

  2005cited by this paper
• Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2

  2005cited by this paper
• Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

  2005cited by this paper
• A Model-Based Background Adjustment for Oligonucleotide Expression Arrays

  2004cited by this paper
• Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

  2004cited by this paper
• Surgical Removal of Primary Tumor Reverses Tumor-Induced Immunosuppression Despite the Presence of Metastatic Disease

  2004cited by this paper
• Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.

  2004cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• DAVID: Database for Annotation, Visualization, and Integrated Discovery

  2003cited by this paper
• Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade

  2003cited by this paper
• DAVID: Database for Annotation, Visualization, and Integrated Discovery

  2003cited by this paper
• CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma.

  2003cited by this paper
• Immunohistochemical Markers for Prognosis of Ependymal Neoplasms

  2002cited by this paper
• Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

  2002cited by this paper
• Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

  2002cited by this paper
• Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

  2002cited by this paper
• Direct Activation of Innate and Antigen-Presenting Functions of Microglia following Infection with Theiler's Virus

  2001cited by this paper
• Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification

  2001cited by this paper
• Human papillomavirus positive squamous cell carcinoma of the oropharynx

  2001cited by this paper
• Prognostic factors in intracranial ependymomas in children.

  2000cited by this paper
• Gene Ontology: tool for the unification of biology

  2000cited by this paper
• Microglia only weakly present glioma antigen to cytotoxic T cells

  1999cited by this paper
• Ki‐67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas

  1998cited by this paper
• Systemic T cell adoptive immunotherapy of malignant gliomas.

  1998cited by this paper
• Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.

  1998cited by this paper
• Pathology and Genetics of Tumours of the Nervous System

  1998cited by this paper
• Second-look surgery for incompletely resected fourth ventricle ependymomas: technical case report.

  1997cited by this paper
• Local application of radiolabeled monoclonal antibodies in the treatment of high grade malignant gliomas

  1997cited by this paper
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

  1996cited by this paper
• Molecular Cloning of a New Interferon-induced Factor That Represses Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression (*)

  1995cited by this paper
• Intracranial ependymomas of childhood: long-term outcome and prognostic factors.

  1995cited by this paper
• Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma.

  1994cited by this paper
• Treatment of intracranial ependymomas of children: review of a 15-year experience.

  1994cited by this paper
• DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood.

  1992cited by this paper

• Profiling extracellular vesicles from cerebrospinal fluid for classification of intradural spinal tumors

  2025cites this paper
• Comprehensive Transcriptomic Profiling of Diverse Brain Tumor Types Uncovers Complex Structures of the Brain Tumor Microenvironment

  2024cites this paper
• Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencing

  2023cites this paper
• The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors

  2023cites this paper
• Expansion of endogenous T cells in CSF of pediatric CNS tumor patients undergoing locoregional delivery of IL13R〿2-targeting CAR T cells: an interim analysis

  2023cites this paper
• Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma

  2023cites this paper
• Microglia in pediatric brain tumors: The missing link to successful immunotherapy

  2023cites this paper
• Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.

  2023cites this paper
• Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma.

  2022cites this paper
• The biology of ependymomas and emerging novel therapies

  2022cites this paper
• The current landscape of immunotherapy for pediatric brain tumors

  2022cites this paper
• Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors.

  2022cites this paper
• Spatial transcriptomic analysis of childhood ependymoma implicates unresolved wound healing as a driver of tumor progression

  2022cites this paper
• Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile

  2021cites this paper
• Role of FUT8 expression in clinicopathology and patient survival for various malignant tumor types: a systematic review and meta-analysis

  2020cites this paper
• Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile

  2020cites this paper
• Ependymomas

  2020cites this paper
• Single-Cell RNA Sequencing of Childhood Ependymoma Reveals Neoplastic Cell Subpopulations That Impact Molecular Classification and Etiology.

  2020cites this paper
• Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?

  2019cites this paper
• Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma

  2018cites this paper
• Specific expression of PD‐L1 in RELA‐fusion supratentorial ependymoma: Implications for PD‐1‐targeted therapy

  2018cites this paper
• Ependymomas

  2018cites this paper
• Transcriptional co-expression regulatory network analysis for Snail and Slug identifies IL1R1, an inflammatory cytokine receptor, to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas

  2018cites this paper
• Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies

  2017cites this paper
• PD1 and PD-L1 in ependymoma might not be therapeutic targets.

  2017cites this paper
• Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood

  2017cites this paper
• Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

  2017cites this paper
• Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma

  2017cites this paper
• Experimental models of pediatric brain tumors. Establishment, immunophenotyping and clinical implications.

  2016cites this paper
• Preoperative systemic levels of VEGFA, IL‐7, IL‐17A, and TNF‐β delineate two distinct groups of children with brain tumors

  2016cites this paper
• Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

  2016cites this paper
• A systems biology approach to integrated molecular analysis in pancreatic and periampullary adenocarcinoma

  2016cites this paper
• The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma.

  2016cites this paper
• Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma

  2015cites this paper
• An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes

  2015cites this paper
• Targeting the Tumor Microenvironment to Enhance Pediatric Brain Cancer Treatment.

  2015cites this paper
• A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays

  2015cites this paper
• Identification of glioma-associated antigens for brain tumor immunotherapy

  2015cites this paper
• Dual roles for immune metagenes in breast cancer prognosis and therapy prediction

  2014cites this paper
• Immunotherapeutic implications of the immunophenotype of pediatric brain tumors

  2014cites this paper
• The fine structure of ependymomas REVIEW

  2014cites this paper
• Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma

  2014cites this paper
• CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy

  2014cites this paper
• The fine structure of ependymomas.

  2014cites this paper
• This information is current as Tumor Types Immunophenotypes across Pediatric Brain Characterization of Distinct

  2013cites this paper
• Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types

  2013cites this paper
• Ependymomas: development of immunotherapeutic strategies

  2013cites this paper
• Current and evolving knowledge of prognostic factors for pediatric ependymomas.

  2013cites this paper
• Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma Lindsey M. HoffmanAndrew M. DonsonIchiro NakachiAndrea M. Griesinger • Diane K. BirksVladimir AmaniMolly S. HemenwayArthur K. Liu • Michael WangTodd C. HankinsonMichael H. Handle

  2013cites this paper
• Multi-study Integration of Brain Cancer Transcriptomes Reveals Organ-Level Molecular Signatures

  2013cites this paper
• Emerging evidence of anti-tumor immune control in the central nervous system

  2012cites this paper
• Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors

  2012cites this paper
• Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy

  2012cites this paper
• Khalida WaniTerri S. ArmstrongElizabeth Vera-BolanosAditya RaghunathanDavid Ellison • Richard GilbertsonBrian VaillantStewart GoldmanRoger J. PackerMaryam FouladiIan Pollack • Tom MikkelsenMichael PradosAntonio OmuroRiccardo SoffiettiAlicia LedouxCharmaine Wilson • Lihong LongMark R. GilbertKen Alda

  2012cites this paper
• A prognostic gene expression signature in infratentorial ependymoma

  2012cites this paper
• Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation.

  2012cites this paper
• Pediatric ependymomas: will molecular biology change patient management?

  2011cites this paper
• BTECH: A Platform to Integrate Genomic, Transcriptomic and Epigenomic Alterations in Brain Tumors

  2011cites this paper
• Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death

  2011cites this paper
• Molecular genetics of ependymoma

  2011cites this paper
• Tumor vaccination for malignant brain tumors

  2010cites this paper
• Aurora kinase A as a rational target for therapy in glioblastoma.

  2010cites this paper
• Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis

  2010cites this paper
• Oncotargets and Therapy Dovepress Dovepress Pilot Study of Intratumoral Injection of Recombinant Heat Shock Protein 70 in the Treatment of Malignant Brain Tumors in Children

  year unknowncites this paper